Jefferies Downgrades Moderna(MRNA.US) to Hold Rating, Cuts Target Price to $50
Baptista Upgrades Moderna to Buy, Price Target at $48
Berenberg Bank Initiates Moderna(MRNA.US) With Hold Rating, Announces Target Price $42
Berenberg Bank Initiates Moderna(MRNA.US) With Hold Rating, Announces Target Price $42
Piper Sandler Reiterates Overweight on Moderna, Lowers Price Target to $69
Moderna Analyst Ratings
HSBC Upgrades Moderna to Buy From Hold, Adjusts Price Target to $58 From $82
Moderna Analyst Ratings
Wolfe Research Downgrades Moderna(MRNA.US) to Sell Rating, Cuts Target Price to $40
Deutsche Bank Adjusts Price Target on Moderna to $60 From $75, Keeps Hold Rating
A Quick Look at Today's Ratings for Moderna(MRNA.US), With a Forecast Between $60 to $112
Moderna Price Target Cut to $111.00/Share From $125.00 by Barclays
Moderna Is Maintained at Overweight by Barclays
BofA Securities Adjusts Price Target on Moderna to $90 From $110, Maintains Neutral Rating
A Quick Look at Today's Ratings for Moderna(MRNA.US), With a Forecast Between $55 to $111
Moderna Analyst Ratings
Brookline Capital Cuts Moderna's Price Target to $212 From $238
Moderna Is Maintained at Underweight by JP Morgan
Moderna Analyst Ratings
Evercore Maintains Moderna(MRNA.US) With Hold Rating, Cuts Target Price to $60